Florida Department of HealthEPI UPDATE

A weekly publication by the Bureau of Epidemiology

August 17, 2001

"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."

--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.

Steven T. Wiersma, MD, MPH—Acting Bureau Chief and State Epidemiologist

Don Ward, Surveillance Section Administrator, Epi Update Managing Editor

Bureau of Epidemiology Frequent Contributors:

Kathryn Snavely, MPH

Reportable Disease Manager

Jodi Baldy, MPH,

Biological Scientist IV

Ursula E. Bauer, PhD,

Chronic Disease Epidemiologist

Lisa Conti, DVM, MPH,

State Public Health Veterinarian

Regional Epidemiologists:

Dolly Katz, PhD, MPH, SE Florida

Roger Sanderson, RN, MA, SW Florida

Carina Blackmore, MS Vet. Med., PhD, NE Florida

Zuber Mulla, PhD MSPH,

Central Florida Carina Blackmore, MS Vet. Med., PhD,

Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.

The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (SunCom 205-4401 or 850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.

The Department of Health has a home on the World Wide Web at http://www.doh.state.fl.us

For information on diseases and conditions of public health importance go to MyFlorida.com, click on Health and Human Services, then Consumers--Diseases and Conditions.

In this Issue:

  1. EEE Alert
  2. August Grand Rounds
  3. No Need for Hard Copies
  4. Proposed Malaria Form
  5. Weekly Disease Table

 

1. EEE Alert

Steven T. Wiersma, Acting Chief, Bureau of Epidemiology and State Epidemiologist

FOR IMMEDIATE RELEASE August 17, 2001

CONTACT: Frank Penela 1-850-245-4111/ 850-933-0375 (cell phone)
Carina Blackmore, DVM, PhD 1-877-631-5445 (toll-free pager)
Steven Wiersma MD, MPH 1-877-210-5031 (toll-free pager)

*** MOSQUITO-BORNE VIRUS UPDATE***

Florida’s Second Human Case of Eastern Equine Encephalitis Confirmed
Medical Alert Extended to 30 Counties with Addition of Levy County

TALLAHASSEE—The Florida Department of Health (DOH) announced today that the second human encephalitis case caused by the Eastern equine encephalitis (EEE) virus has been confirmed. The case was reported in a 39-year-old male who was most likely exposed to the disease in Levy County. There have been two confirmed human cases of WN virus encephalitis and two confirmed cases of Eastern equine encephalitis.

A previous medical alert issued by health officials for EEE and West Nile virus has now been extended to include Levy County. The alert is now in effect for 30 north Florida counties, including: Baker, Bay, Bradford, Calhoun, Clay, Columbia, Duval, Escambia, Franklin, Gadsden, Gulf, Hamilton, Holmes, Jackson, Jefferson, Lafayette, Leon, Levy, Liberty, Madison, Nassau, Okaloosa, Santa Rosa, St. Johns, Suwannee, Taylor, Union, Wakulla, Walton and Washington counties.

The Department of Health urges all Floridians to take precautions against mosquito bites. DOH is recommending the following:

The Department of Health continues to track mosquito-borne viruses in dead birds collected by citizens, through the regular testing of sentinel chickens, through horse test results provided by the Department of Agriculture and Consumer Services, and through reports of human disease from Florida physicians.

Physicians are urged to report all cases of encephalitis and meningitis to their local health department. Laboratory testing by the DOH is available to physicians free-of-charge.

Animal surveillance for WN virus has detected 38 confirmed-positive dead birds, 31 horses, and 3 sentinel chickens all from counties covered by the medical alert. EEE virus surveillance has detected 20 confirmed-positive horses, none of which were reported in Levy county.

For more information on mosquito-borne encephalitis, including reporting human cases and dead birds, visit the DOH Bureau of Epidemiology’s Arboviral Encephalitis and West Nile Virus website at MyFlorida.com (click on Health and Human Services, then Consumers – Diseases and Conditions, then Arboviral Encephalitis) or http://www.doh.state.fl.us/disease_ctrl/epi/htopics/arbo/index.htm, or call the Bureau’s hotline at 1-888-880-5782 for recorded information.

###

 

2. Grand Rounds Tuesday August 28, 2001

Melanie Black, MSW, Professional Training Coordinator, Bureau of Epidemiology

"Invasive Group A Streptococcal Infections in Florida: Risk Factors for Hospital Mortality"

Zuber D. Mulla, MSPH 1,2; Paul E. Leaverton, PhD 1, Steven T. Wiersma, MD, MPH 2

  1. Department of Epidemiology and Biostatistics, University of South Florida, Tampa, FL
  2. Bureau of Epidemiology, Florida Department of Health, Tallahassee, FL

11:00 AM – 12:00 PM EST

Dial-in by 11:10 AM at (850) 487-8587 or SunCom 277-8587

Abstract

Group A Streptococcus can cause serious infections such as necrotizing fasciitis, septicemia, and toxic shock syndrome. Several previous studies of invasive group A streptococcal disease had small sample sizes (£ 100 patients) and only included patients from one or two hospitals. We conducted a population-based study of invasive group A streptococcal disease in Florida. The objectives of the study were to describe the clinical features of individuals who were hospitalized for invasive group A streptococcal disease and to identify risk factors for hospital mortality. The cases were 257 patients who were hospitalized throughout Florida between August of 1996 and August of 2000 and were reported to the Florida Department of Health’s Bureau of Epidemiology.

Skin was the most common focus of infection. Twenty-two percent of the cases had primary bacteremia (57/256). Multiple logistic regression was used to calculate adjusted odds ratios (AOR) for hospital mortality and 95% confidence intervals (CI). A total of 195 patient records were included in the multivariate analyses. Admission into an intensive care unit was a strong predictor of mortality (AOR=20.41, 95% CI: 6.41-64.96). Risk of mortality increased with age. Treatment with clindamycin protected against mortality in patients who had necrotizing fasciitis (AOR=0.11, 95% CI: 0.01-0.89) but not in patients who did not have necrotizing fasciitis (AOR=1.01, 95% CI: 0.31-3.33).

Additional Information

Further details regarding the audio-conference call and PowerPoint files will be posted on the Bureau of Epidemiology Intranet web site. Be sure and register online at the end of the program to obtain nursing CEU’s and laboratory contact hours for this program. Information about upcoming topics and presenters will also be posted in the Epi Update. If either of these access points is unavailable to you, please email Melanie Black [Melanie_Black@doh.state.fl.us] or telephone (850) 245-4444 ext. 2448 (SunCom 205-4444 ext. 2448) to request presentation materials.

Important

While we realize you might not always be able to call in at 11:00 AM, it can be distracting to the speaker and others in the audience when participants dial-in throughout the hour. Please try to call in on time and remember to put your phones on mute so as not to disturb others. Thank you for your cooperation.

 

 

3. Hepatitis Extended Data--No Need for Sending Hard Copies

Kathryn Snavely, MPH, Reportable Disease Manager

The Bureau of Epidemiology is no longer accepting paper hepatitis case report forms from county health departments. With the extended data screens in place we are able to collect data electronically, eliminating the need for county health departments to send in paper Acute Viral Hepatitis forms. All the necessary data fields for the CDC NETSS weekly transmission, which were previously manually entered from paper forms, are gathered from the Merlin extended data screens. All changes to the extended data screens can be done at any time and the case will be flagged as an update.

 

 

4. Proposed New Malaria Case Report Form

Don Ward, Surveillance Section Administrator

In January, we provided county health department epidemiology programs with a proposed (CDC) new case report form for malaria. We asked for a trial use of the form and for comments regarding its utility. We received a number of comments and suggestions, which we have forwarded to the malaria program staff at CDC. The CDC staff are currently revising the form, and intend to have an updated version available later in the fall.  We are now asking that the use of the test version be discontinued and county health departments return to the use of the previous standard form. Thank you all for your comments and recommendations; I know that CDC appreciates your efforts.

 

 

5. Weekly Disease Table (Week 32)

DISEASE

1999 TO
WEEK 32

2000 TO
WEEK 32

3-YEAR
AVERAGE
TO WEEK 32*

2000
TOTAL
CASES

2001 TO
WEEK 32

2001
WEEK 32
ONLY

Animal Rabies

114

89

110

161

137

7

Anthrax

0

0

0

0

0

0

Botulism, foodborne

0

0

0

0

0

0

Botulism, infant

0

0

0

0

0

0

Botulism, wound

0

0

0

0

0

0

Botulism, other

0

0

0

0

0

0

Brucellosis

0

2

1.3

2

1

0

Campylobacteriosis

548

574

517.7

1026

538

17

Ciguatera

2

1

3

14

0

0

Cryptosporidiosis

71

48

63.7

180

46

2

Cyclosporiasis

3

6

5

9

27

0

Dengue Fever

2

1

1.3

3

3

0

Diphtheria

0

0

0

0

0

0

Ehrlichiosis, human

1

0

0.3

0

0

0

Encephalitis, chickenpox

0

0

0

0

0

0

Encephalitis, Eastern Equine

0

0

0

0

1

0

Encephalitis, herpes

3

3

3

7

1

0

Encephalitis, influenza

0

1

0.3

1

0

0

Encephalitis, measles

0

0

0

0

0

0

Encephalitis, mumps

0

0

0

0

0

0

Encephalitis, other

5

6

6

8

2

0

Encephalitis, St. Louis

0

0

0

0

0

0

Encephalitis, Venezuelan

0

0

0

0

0

0

Encephalitis, Western Equine

0

0

0

0

0

0

Escherichia Coli 0157:H7

29

43

30.7

95

19

0

Escherichia Coli, other

12

6

6.7

13

9

2

Giardiasis

606

727

691.3

1466

599

22

H. Influenzae Cellulitis

0

0

0.7

1

0

0

H. Influenzae Epiglottitis

0

0

0

1

0

0

H. Influenzae Meningitis

11

3

8.3

11

6

0

H. Influenzae Pneumonia

3

2

2.7

7

12

0

H. Influenzae Prim.Bacteremia

20

23

18.7

57

47

1

H. Influenzae Septic Arthritis

0

0

0

1

0

0

Hantaviris Infection

0

0

0

0

0

0

Hemolytic Uremic Syndrome

6

8

6.7

18

2

0

Hemorrhagic Fever

0

0

0

0

0

0

Hepatitis A

381

283

322

589

346

19

Hepatitis B

241

269

247.7

525

247

12

Hepatitis B (+HbsAg in pregnant women)

36

241

92.3

493

248

12

Hepatitis, Perinatal Hep B

1

1

0.7

1

4

0

Hepatitis C

30

11

13.7

19

14

0

Hepatitis, Non-A, Non-B

3

5

19.7

6

2

0

Hepatitis, Other, including unspecified

9

6

7.3

7

4

0

Lead Poisoning

990

672

907.3

1219

380

7

Legionellosis

14

25

20.3

51

45

3

Leprosy

2

2

2.3

4

0

0

Leptospirosis

0

1

0.7

2

0

0

Listeriosis

15

17

10.7

32

13

0

Lyme Disease

14

15

17.3

54

15

1

Malaria

52

48

45

90

32

2

Measles

2

1

1.7

2

0

0

Meningitis, Group B Strep

9

11

10.3

21

9

0

Meningitis, List Monocytogenes

6

3

4.3

7

0

0

Meningitis, Meningococcal

27

24

27

41

39

1

Meningitis, other

32

55

41.3

110

52

2

Meningitis, Strep Pneumoniae

71

65

63.7

112

38

1

Meningococcemia, disseminated

43

47

48

80

44

3

Mercury Poisoning

2

7

3

11

2

0

Mumps

2

2

4.3

4

2

0

Neurotoxic Shellfish Poisoning

0

0

0

0

0

0

Pertussis

53

35

37

48

14

1

Plague, Bubonic

0

0

0

0

0

0

Plague, Pneumonic

0

0

0

0

0

0

Poliomyelitis

0

0

0

0

0

0

Psittacosis

0

0

0.3

3

0

0

Q Fever

0

0

0

0

0

0

Human Rabies

0

0

0

0

0

0

Rocky Mountain Spotted Fever

2

0

1

1

2

0

Rubella

0

2

1.7

2

1

0

Rubella, Congenital

0

1

0.3

1

0

0

Salmonellosis

1316

1249

1253.7

2755

1346

96

Shigellosis

833

783

954.3

1292

466

30

Smallpox

0

0

0

0

0

0

Staphylococcus Aureus (GISA/VISA)

0

0

0

0

0

0

Staphylococcus Aureus (GRSA/VRSA)

0

0

0

0

0

0

Streptococcal Disease, Invasive Group A

38

74

46.7

146

103

4

Streptococcus Pneumoniae, Invasive

351

633

424.3

1147

577

9

Tetanus

2

0

1.3

1

3

0

Toxoplasmosis

9

6

7.3

12

18

4

Trichinosis

1

0

0.3

1

0

0

Tularemia

0

0

0

0

0

0

Typhoid Fever

21

6

12.3

12

4

0

Vibrio Alginolyticus

6

7

5.3

15

2

0

Vibrio Cholerae Type 01

0

0

0

0

0

0

Vibrio Cholerae Non-01

7

4

5.7

4

4

0

Vibrio Fluvialis

3

1

2.7

2

2

0

Vibrio Hollisae

4

3

3.3

3

0

0

Vibrio Mimicus

1

2

2

2

1

0

Vibrio, other

2

0

1

2

0

0

Vibrio Parahaemolyticus

8

7

15.7

16

7

0

Vibrio Vulnificus

10

3

9.3

13

7

1

Yellow Fever

0

0

0

0

0

0

* The column of data representing the "3-year average to week ##" is the average of years 1998, 1999 and 2000 cases to the current listed week (##).